GALECTIN THERAPEUTICS INC (GALT) Stock Balance Sheet
NASDAQ:GALT - Nasdaq - US3632252025 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.43M | 15.12M | 25.66M | 18.59M | 39.65M | |||
| Other Current Assets | 1.85M | 2.13M | 2.05M | 1.96M | 2.17M | |||
| Total Current Assets | 9.29M | 17.25M | 27.71M | 20.55M | 41.82M | |||
| Non-Current Assets | ||||||||
| PPE Net | 66.00K | 16.00K | 53.00K | 90.00K | 10.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 177.00K | 227.00K | 437.00K | 650.00K | N/A | |||
| Total Non-Current Assets | 243.00K | 243.00K | 490.00K | 740.00K | 10.00K | |||
| TOTAL ASSETS | 9.53M | 17.50M | 28.20M | 21.29M | 41.83M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 21.28M | 21.12M | N/A | N/A | N/A | |||
| Accrued Expenses | 82.72M | 8.20M | 9.18M | 9.06M | 7.16M | |||
| Accounts Payable | 6.53M | 5.66M | 6.43M | 3.89M | 1.81M | |||
| Other Current Liabilities | 305.00K | 432.00K | 63.00K | 60.00K | 70.00K | |||
| Total Current Liabilities | 110.84M | 35.41M | 15.68M | 13.01M | 9.03M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 10.81M | 85.11M | 71.74M | 39.83M | 29.05M | |||
| Other Non-Current Liabilities | 136.00K | 47.00K | 1.02M | 640.00K | 1.13M | |||
| Total Non-Current Liabilities | 10.95M | 85.16M | 72.77M | 40.47M | 30.18M | |||
| TOTAL LIABILITIES | 121.79M | 120.56M | 88.44M | 53.48M | 39.21M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -411.18M | -401.57M | -354.37M | -309.57M | -270.69M | |||
| Additional Paid In Capital | 296.63M | 296.22M | 291.85M | 275.08M | 271.00M | |||
| Common Shares | 2.29M | 2.29M | 2.28M | 2.29M | 2.31M | |||
| Shares Outstanding | 63.29M | 63.16M | 61.85M | 59.43M | 59.34M | |||
| Tangible Book Value per Share | -1.81 | -1.67 | -1.01 | -0.58 | 0.01 | |||
| Total Shareholders' Equity | -112.26M | -103.07M | -60.24M | -32.19M | 2.62M | |||
| TOTAL LIABILITIES AND EQUITY | 9.53M | 17.50M | 28.20M | 21.29M | 41.83M | |||
| Statistics | ||||||||
| Debt/Equity | -0.10 | -0.83 | -1.19 | -1.24 | 11.09 | |||
| Current Ratio | 0.08 | 0.49 | 1.77 | 1.58 | 4.63 | |||
| Return On Assets (ROA) | -475.52% | -269.79% | -158.88% | -182.57% | -73.39% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -1171.76% | |||
All data in USD , ROIC based on taxRate of 0.21